List of Revvity ChemDraw Customers
Waltham, 2451, MA,
United States
Since 2010, our global team of researchers has been studying Revvity ChemDraw customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Revvity ChemDraw for Chemistry Simulation from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Revvity ChemDraw for Chemistry Simulation include: AstraZeneca, a United Kingdom based Life Sciences organisation with 94300 employees and revenues of $73.98 billion, Sygnature Discovery, a United Kingdom based Professional Services organisation with 204 employees and revenues of $33.6 million and many others.
Contact us if you need a completed and verified list of companies using Revvity ChemDraw, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Revvity ChemDraw customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
AstraZeneca | Life Sciences | 94300 | $74.0B | United Kingdom | Revvity | Revvity ChemDraw | Chemistry Simulation | 2024 | n/a |
In 2024, AstraZeneca implemented Revvity ChemDraw within a broader Revvity Signals Notebook deployment to modernize chemistry and biology data capture. The implementation is categorized under Chemistry Simulation and targeted research and development activities in the United Kingdom, onboarding more than 3,800 scientists during an 18 month accelerated rollout. The vendor case study documents native Signals ChemDraw integration with Signals Notebook, establishing the chemistry editor as an embedded capability inside the electronic lab notebook.
Deployment focused on embedding Revvity ChemDraw as the primary chemical sketching and structure capture tool inside the electronic lab notebook environment, enabling direct molecular editing and reaction annotation adjacent to experimental records. Functional capabilities implemented included structured chemistry and biology data capture, collaboration features for shared entries, and AI assisted experiment summarization to surface experiment level insights. Configuration emphasized standardized templates and controlled vocabularies to support consistent data reuse across projects.
Integrations were explicit, with Revvity ChemDraw natively integrated into Revvity Signals Notebook to create a unified capture and metadata store for R&D experiments. Operational coverage included AstraZeneca research and development groups across the United Kingdom, with centralized provisioning and rapid user onboarding for the cited scientific population. Data flow centered on in notebook chemical structure artifacts linked to experimental metadata for downstream analysis and reuse.
Governance changes aligned with the rollout, instituting standardized ELN usage, centralized data capture policies, and accelerated training programs to support rapid adoption across scientific teams. The implementation aimed to improve collaboration and data reuse, and to enable AI assisted experiment summarization as part of routine R&D workflows.
|
 |
Sygnature Discovery | Professional Services | 204 | $34M | United Kingdom | Revvity | Revvity ChemDraw | Chemistry Simulation | 2024 | n/a |
In 2024, Sygnature Discovery implemented Revvity Signals Notebook and integrated Revvity ChemDraw to support chemistry data capture and sample metadata management in a Chemistry Simulation context. The UK based implementation included Canadian sites and focused on R&D and chemistry process areas within the company’s contract research organization workflows.
The deployment centralized electronic laboratory notebook workflows through Revvity Signals Notebook while using Revvity ChemDraw for structure drawing, reaction capture, and standardized chemical metadata exchange. Configuration emphasized data capture templates, standardized metadata fields, and experiment record schemas to enforce consistent sample lifecycle tracking across projects. These functional capabilities supported core chemistry process workflows and experiment documentation.
Integration between Revvity Signals Notebook and Revvity ChemDraw was implemented to ensure chemistry data and sample metadata are synchronized for downstream automation and client reporting. The operational scope covered R&D and chemistry teams and CRO delivery pipelines across Sygnature Discovery’s UK headquarters and Canadian sites. The integration created consistent chemistry data handoffs between bench scientists and reporting workflows.
Governance focused on standardized templates and process controls to enforce metadata and experiment record quality, aligning with compliance needs for client engagements. The implementation improved data consistency, compliance and downstream automation for client reporting as stated in the vendor case study.
|
Buyer Intent: Companies Evaluating Revvity ChemDraw
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||